466 related articles for article (PubMed ID: 11964077)
1. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
[TBL] [Abstract][Full Text] [Related]
2. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
Davidson B; Risberg B; Goldberg I; Nesland JM; Berner A; Tropé CG; Kristensen GB; Bryne M; Reich R
Am J Surg Pathol; 2001 Dec; 25(12):1493-500. PubMed ID: 11717538
[TBL] [Abstract][Full Text] [Related]
3. Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study.
Davidson B; Goldberg I; Kopolovic J; Gotlieb WH; Givant-Horwitz V; Nesland JM; Berner A; Ben-Baruch G; Bryne M; Reich R
Clin Exp Metastasis; 2000; 18(6):501-7. PubMed ID: 11592307
[TBL] [Abstract][Full Text] [Related]
4. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
7. Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma.
Davidson B; Vintman L; Zcharia E; Bedrossian C; Berner A; Nielsen S; Ilan N; Vlodavsky I; Reich R
Clin Exp Metastasis; 2004; 21(5):469-76. PubMed ID: 15672872
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
10. Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma.
Givant-Horwitz V; Davidson B; van de Putte G; Dong HP; Goldberg I; Amir S; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(7):599-609. PubMed ID: 14669791
[TBL] [Abstract][Full Text] [Related]
11. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic protein expression in advanced epithelial ovarian cancer.
Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
14. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases.
Vaksman O; Davidson B; Tropé C; Reich R
Hum Pathol; 2013 Dec; 44(12):2677-83. PubMed ID: 24060004
[TBL] [Abstract][Full Text] [Related]
16. [The expression and significance of VEGF mRNA and bFGF mRNA in the malignant neoplasms of ovary].
Li L; Liu YZ; Wu YL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):406-8. PubMed ID: 12206019
[TBL] [Abstract][Full Text] [Related]
17. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
18. Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?
Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Risberg B; Ben-Baruch G; Reich R
Cancer Metastasis Rev; 2003 Mar; 22(1):103-15. PubMed ID: 12716042
[TBL] [Abstract][Full Text] [Related]
19. Expression of metastasis-related genes in human epithelial ovarian tumors.
Herrera CA; Xu L; Bucana CD; Silva el VG; Hess KR; Gershenson DM; Fidler IJ
Int J Oncol; 2002 Jan; 20(1):5-13. PubMed ID: 11743636
[TBL] [Abstract][Full Text] [Related]
20. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
Davidson B; Trope' CG; Wang TL; Shih IeM
Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
